NCT03138603
Metoprolol to Reduce Perioperative Myocardial Injury
See it on ClinicalTrials.gov ↗72 people
59.7%
40.3%
43 womenmiddle line = equal numbers29 men
- Phase
- PHASE3
- Paid for by
- University of Chicago
- Finished
- 2023-08-29
- Health conditions
- Heart Diseases
- Who could join
- Anyone
- Ages
- 50 Years – no maximum
- Average age
- Not reported
- Age 65+
- 86.1%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 77.8% · Black / African American 16.7% · Asian 2.8% · More than one race 1.4% · Not reported 1.4% · American Indian / Alaska Native 0% · Native Hawaiian / Pacific Islander 0%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnancy or lactating women”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnancy or lactating women”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Congestive heart failure with New York Heart Association(NYHA) Functional Classification of III-IV or left ventricular heart failure with ejection fraction ≤50%”
Study titles and rules are shown in their original English.